Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HAIRY-CELL LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 606 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mazzoran, L; Zorat, F; Chemello, L; Croce, LS; Rigato, I; Cavalletto, L; Bernardinello, E; Tiribelli, C; Alberti, A; Pozzato, G
      Human leucocyte interferon-alpha in the treatment of chronic hepatitis C

      DIGESTIVE AND LIVER DISEASE
    2. Honma, Y
      A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors

      LEUKEMIA & LYMPHOMA
    3. Saif, MW; Greenberg, BR
      Multiple myeloma and hairy cell leukemia: A rare association or coincidence?

      LEUKEMIA & LYMPHOMA
    4. Undar, B; Demirkan, F; Oztop, I; Ozcan, MA; Ozsan, GH
      Concurrent diagnosis of hairy cell leukemia and renal cell carcinoma

      LEUKEMIA & LYMPHOMA
    5. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
      Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells

      LEUKEMIA & LYMPHOMA
    6. Robak, T; Blonski, JZ; Kasznicki, M
      Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?

      LEUKEMIA & LYMPHOMA
    7. Van den Neste, E; Delannoy, A; Feremans, W; Ferrant, A; Michaux, L
      Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment

      LEUKEMIA & LYMPHOMA
    8. Robak, T
      Cladribine in the treatment of chronic lymphocytic leukemia

      LEUKEMIA & LYMPHOMA
    9. Wong, SSY; Woo, PCY; Yuen, KY
      Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenstrom's macroglobulinaemia

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    10. Badid, C; McGregor, B; Faivre, JM; Guerard, A; Juillard, L; Fouque, D; Laville, M
      Renal thrombotic microangiopathy induced by interferon-alpha

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    11. Gillis, S; Amir, G; Bennett, M; Polliack, A
      Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy

      EUROPEAN JOURNAL OF HAEMATOLOGY
    12. Kremer, M; Dirnhofer, S; Nickl, A; Hoefler, H; Quintanilla-Martinez, L; Fend, F
      p27(Kip1) immunostaining for the differential diagnosis of small B-cell neoplasms in trephine bone marrow biopsies

      MODERN PATHOLOGY
    13. Yetgin, S; Olcay, L; Yenicesu, I; Oner, AF; Caglar, M
      Relapse in hairy cell leukemia due to isolated nodular skin infiltration

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    14. Cohen, RB; Dittrich, KA
      Anti-TNF therapy and malignancy - A critical review

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    15. Safdar, A; Armstrong, D
      Infectious morbidity in critically ill patients with cancer

      CRITICAL CARE CLINICS
    16. Munoz, L; Nomdedeu, JF; Lopez, O; Carnicer, MJ; Bellido, M; Aventin, A; Brunet, S; Sierra, J
      Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies

      HAEMATOLOGICA
    17. Cornfield, DB; Nelson, DMM; Rimsra, LM; Moller-Patti, D; Braylan, RC
      The diagnosis of hairy cell leukemia can be established by flow cytometricanalysis of peripheral blood, even in patients with low levels of circulating malignant cells

      AMERICAN JOURNAL OF HEMATOLOGY
    18. Brandt, L; Brandt, J; Olsson, H; Anderson, H; Moller, T
      Gender and time differences in initial location and histological grade of non-Hodgkin's lymphomas in Southern Sweden

      ACTA ONCOLOGICA
    19. Goedert, JI; Fung, MM; Felton, S; Battjes, RJ; Engels, EA
      Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA

      AIDS
    20. Grigoryeva, MA; Tsyba, NN; Kovaleva, LG; Polyanskaya, AM
      Recombinant interferon-alpha in the treatment of hairy-cell leukemia: datafrom long-term study.

      GEMATOLOGIYA I TRANSFUZIOLOGIYA
    21. Morroni, M; Barbatelli, G
      Stages of development of the ribosome-lamella complex: An ultrastructural study

      ULTRASTRUCTURAL PATHOLOGY
    22. Weinmann, M; Becker, G; Einsele, H; Bamberg, M
      Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemia and myeloproliferative disorders

      RADIOTHERAPY AND ONCOLOGY
    23. Andrey, J; Saven, A
      Therapeutic advances in the treatment of hairy cell leukemia

      LEUKEMIA RESEARCH
    24. Robak, T; Gora-Tybor, J
      Cladribine combined with mitoxantrone in the treatment of blastic phase ofchronic myeloid leukemia

      NEOPLASMA
    25. Zak, P; Chrobak, L; Dedic, K
      The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission

      NEOPLASMA
    26. Gharib, AM; Stern, EJ
      Radiology of pneumonia

      MEDICAL CLINICS OF NORTH AMERICA
    27. Deneys, V; Mazzon, AM; Marques, JL; Benoit, H; De Bruyere, M
      Reference values for peripheral blood B-lymphocyte subpopulations: a basisfor multiparametric immunophenotyping of abnormal lymphocytes

      JOURNAL OF IMMUNOLOGICAL METHODS
    28. Safaeian, M; Wilson, LE; Taylor, E; Thomas, DL; Vlahov, D
      HTLV-II and bacterial infections among injection drug users

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Fam, AG
      Paraneoplastic rheumatic syndromes

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    30. Ahmad, I; Al-Katib, AM; Beck, FWJ; Mohammad, RM
      Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: Case report

      CLINICAL CANCER RESEARCH
    31. Tsambiras, PE; Tsambiras, BM; Greene, JN; Sandin, RL; Vincent, AL; Gompf, S
      Legionella pneumophila pneumonia in cancer patients: Case report and review

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    32. Sarmiento, MA; Neme, D; Fornari, MC; Bengio, RM
      Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for hairy cell leukemia

      LEUKEMIA & LYMPHOMA
    33. Honma, Y; Niitsu, N
      Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia

      LEUKEMIA & LYMPHOMA
    34. Paydas, S; Sahin, B; Hazar, B; Yavuz, S
      The association of thyrotoxicosis and chronic lymphoproliferative disorders

      LEUKEMIA & LYMPHOMA
    35. Xie, XY; Sorbara, L; Kreitman, RJ; Fukushima, PI; Kingma, DW; Stetler-Stevenson, M
      Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia

      LEUKEMIA & LYMPHOMA
    36. Tetreault, SA; Saven, A
      Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenstrom macroglobulinemia

      LEUKEMIA & LYMPHOMA
    37. D'Arena, G; Keating, MJ; Carotenuto, M
      Chronic lymphoproliferative disorders: An integrated point of view for thedifferential diagnosis

      LEUKEMIA & LYMPHOMA
    38. Ocvirk, J; Stabuc, B; Rudolf, Z; Galvani, V; Curin-Serbec, V
      Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients

      MELANOMA RESEARCH
    39. Kuwayama, M; Machii, T; Yamaguchi, M; Yamaguti, K; Kitani, T; Kanakura, Y
      Blastic transformation of splenic lymphoma with villous lymphocytes after a well-controlled chronic phase of more than 10 years

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    40. Hutson, TE; Hoffman, GS
      Temporal concurrence of vasculitis and cancer: A report of 12 cases

      ARTHRITIS CARE AND RESEARCH
    41. Miranda, RN; Briggs, RC; Kinney, MC; Veno, PA; Hammer, RD; Cousar, JB
      Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia

      MODERN PATHOLOGY
    42. Johnson, JM; Mulloy, JC; Ciminale, V; Fullen, J; Nicot, C; Franchini, G
      The MHC class I heavy chain is a common target of the small proteins encoded by the 3 ' end of HTLV type 1 and HTLV type 2

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    43. Roman, V; Zhao, H; Fourneau, JM; Marconi, A; Dugas, N; Dugas, B; Sigaux, F; Kolb, JP
      Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line

      LEUKEMIA
    44. Konig, EA; Kusser, WC; Day, C; Porzsolt, F; Glickman, BW; Messer, G; Schmid, M; de Chatel, R; Marcsek, ZL; Demeter, J
      P53 mutations in hairy cell leukemia

      LEUKEMIA
    45. Lauta, VM
      Pharmacological elements in clinical application of synthetic peptides

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    46. Powell, FC; Collins, S
      Pyoderma gangrenosum

      CLINICS IN DERMATOLOGY
    47. Hensley, CD; Caughman, SW
      Neutrophilic dermatoses associated with hematologic disorders

      CLINICS IN DERMATOLOGY
    48. Kreitman, RJ; Wilson, WH; White, JD; Stetler-Stevenson, M; Jaffe, ES; Giardina, S; Waldmann, TA; Pastan, I
      Phase I trial of recombinant immunotoxin anti-Tac(Fv)PE38 (LMB-2) in patients with hematologic malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    49. Nieto, LH; Sanchez, JMR; Arguelles, HA; Barroso, MLB; Gonzalez, BG
      A case of chronic lymphocytic leukemia overwhelmed by rapidly progressing idiopathic myelofibrosis

      HAEMATOLOGICA
    50. Pileri, SA; Ascani, S; Sabatini, E; Fraternali-Orcioni, G; Poggi, S; Piccioli, M; Piccaluga, PP; Gamberi, B; Zinzani, PL; Leoncini, L; Falini, B
      The pathologist's view point. Part I - indolent lymphomas

      HAEMATOLOGICA
    51. Bengio, R; Narbaitz, MI; Sarmiento, MA; Palacios, MF; Scolnik, MP
      Comparative analysis of immunophenotypic methods for the assessment of minimal residual disease in hairy cell leukemia

      HAEMATOLOGICA
    52. Yetgin, S; Olcay, L; Yel, L; Tuncer, M; Tezcan, I; Erdemli, E; Oner, AF; Behm, FG
      T-ALL with monoclonal gammopathy and hairy cell features

      AMERICAN JOURNAL OF HEMATOLOGY
    53. Paolini, R; Poletti, A; Ramazzina, E; Menin, C; Santacatterina, M; Montagna, M; Bonaldi, L; Del Mistro, A; Zamboni, S; D'Andrea, E
      Co-existence of cutaneous T-cell lymphoma and B hairy cell leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    54. Sonderegger, T; Betticher, DC; Cerny, T; Lauterburg, BH
      Pharmacokinetics of 2-chloro-2 '-deoxyadenosine administered subcutaneously or by continuous intravenous infusion

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    55. Johnson, SA
      Clinical pharmacokinetics of nucleoside analogues - Focus on haematological malignancies

      CLINICAL PHARMACOKINETICS
    56. Diebold, J; Molina, T; Camilleri-Broet, S; le Tourneau, A; Audouin, J
      Bone marrow manifestations of infections and systemic diseases observed inbone marrow trephine biopsy

      HISTOPATHOLOGY
    57. Takeuchi, H; Kayano, H; Hirose, T
      Differences in IgE isotype switching induced by anti-CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias

      EXPERIMENTAL HEMATOLOGY
    58. Vial, T; Choquet-Kastylevsky, G; Liautard, C; Descotes, J
      Endocrine and neurological adverse effects of the therapeutic interferons

      TOXICOLOGY
    59. Au, WY; Kwong, YL; Ma, SK; Mak, YK; Wong, KF; Lei, KI; Ng, MH; Chan, JCW; Lin, SY; Lee, KK; Liang, R
      Hairy cell leukemia in Hong Kong Chinese: A 12-year retrospective survey

      HEMATOLOGICAL ONCOLOGY
    60. Duchini, A; Younossi, ZM; Saven, A; Bordin, GM; Knowles, HJ; Pockros, PJ
      An open-label pilot trial of cladibrine (2-chlorodeoxyadenosine) in patients with primary sclerosing cholangitis

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    61. Choschzick, M; Hantschick, M; Stosiek, P
      Diagnostic value of flow cytometry in staging of malignant lymphoma

      PATHOLOGE
    62. Seshadri, P; Hadges, S; Cropper, T
      Acute necrotising vasculitis in hairy cell leukemia - rapid response to cladribine: case report and a brief review of the literature

      LEUKEMIA RESEARCH
    63. Pai, VB; Nahata, MC
      Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention

      DRUG SAFETY
    64. Brell, J; Kalaycio, M
      Leukemia in pregnancy

      SEMINARS IN ONCOLOGY
    65. Margolis, J; Grever, MR
      Pentostatin (Nipent): A review of potential toxicity and its management

      SEMINARS IN ONCOLOGY
    66. Dearden, CE; Matutes, E; Catovsky, D
      Clinical overview of pentostatin (Nipent) use in lymphoid malignancies

      SEMINARS IN ONCOLOGY
    67. Margolis, J; Vogelsang, G
      An old drug for a new disease: Pentostatin (Nipent) in acute graft-versus-host disease

      SEMINARS IN ONCOLOGY
    68. Bazzoni, F; Gatto, L; Lenzi, L; Vinante, F; Pizzolo, G; Zanolin, E; De Gironcoli, M
      Identification of novel polymorphisms in the human TNFR1 gene: distribution in acute leukemia patients and healthy individuals

      IMMUNOGENETICS
    69. Nordstrom, M; Hardell, L; Lindstrom, G; Wingfors, H; Hardell, K; Linde, A
      Concentrations of organochlorines related to titers to Epstein-Barr virus early antigen IgG as risk factors for hairy cell leukemia

      ENVIRONMENTAL HEALTH PERSPECTIVES
    70. Dutcher, JP; Novik, Y; O'Boyle, K; Marcoullis, G; Secco, C; Wiernik, PH
      20th-century advances in drug therapy in oncology - Part I

      JOURNAL OF CLINICAL PHARMACOLOGY
    71. Dresser, MJ; Gerstin, KM; Gray, AT; Loo, DDF; Giacomini, KM
      Electrophysiological analysis of the substrate selectivity of a sodium-coupled nucleoside transporter (RCNT1) expressed in Xenopus laevis oocytes

      DRUG METABOLISM AND DISPOSITION
    72. Ogawa, K; Shichishima, T; Nakamura, N; Maruyama, Y
      Induction of apoptosis in vivo and in vitro in hairy cell leukemia treatedby deoxycoformycin

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    73. Acebo, E; Rodilla, IG; Torio, B; Hernando, M; De Polavieja, MG; Morales, D; Seco, I; Bermudez, A
      Papillary cystic tumor of the pancreas coexisting with hairy cell leukemia

      PATHOLOGY
    74. Bengio, R; Narbaitz, M; Palacios, F; Scolnik, M; Sarmiento, M
      Hairy cell leukemia. An alternative method for the detection of minimal residual disease using flow cytometry.

      MEDICINA-BUENOS AIRES
    75. Tsiodras, S; Samonis, G; Keating, MJ; Kontoyiannis, DP
      Infection and immunity in chronic lymphocytic leukemia

      MAYO CLINIC PROCEEDINGS
    76. Harris, RJ; Pettitt, AR; Schmutz, C; Sherrington, PD; Zuzel, M; Cawley, JC; Griffiths, SD
      Granuloctye-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes

      JOURNAL OF IMMUNOLOGY
    77. Rafel, M; Cervantes, F; Beltran, JM; Zuazu, F; Nieto, LH; Rayon, C; Talavera, JG; Montserrat, E
      Deoxycoformycin in the treatment of patients with hairy cell leukemia - Results of a Spanish collaborative study of 80 patients

      CANCER
    78. Juneja, S; Trute, L; Westerman, D; Venter, D; Seymour, JF; Prince, HM
      Paraffin section immunotyping of leukaemias

      BRITISH JOURNAL OF HAEMATOLOGY
    79. Flinn, IW; Byrd, JC; Morrison, C; Jamison, J; Diehl, LF; Murphy, T; Piantadosi, S; Seifter, E; Ambinder, RF; Vogelsang, G; Grever, MR
      Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies

      BLOOD
    80. Abelev, GI
      Differentiation mechanisms and malignancy

      BIOCHEMISTRY-MOSCOW
    81. Potard, M; Ansart, S; Hutin, P; Quintin-Roue, I; Leroy, JP; Pennec, YL
      Lymphoma involving the temporal artery.

      ANNALES DE MEDECINE INTERNE
    82. Guillevin, L; Cohen, P
      Polyarteritis nodosa: clinical, prognostic and therapeutic features.

      ANNALES DE MEDECINE INTERNE
    83. Usha, L; Bradlow, B; Stock, W; Platanias, LC
      CD5+immunophenotype in the bone marrow but not in the peripheral blood in a patient with hairy cell leukemia

      ACTA HAEMATOLOGICA
    84. Schirmer, M; Haun, M; Grunewald, K; Geisen, F; Hilbe, W; Thaler, J; Konwalinka, G
      New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine

      ACTA HAEMATOLOGICA
    85. van de Corput, L; Falkenburg, JHF; Kester, MGD; Willemze, R; Kluin-Nelemans, JC
      Impaired expression of CD28 on T cells in hairy cell leukemia

      CLINICAL IMMUNOLOGY
    86. Lindemalm, SN; Liliemark, J; Larsson, BS; Albertioni, F
      Distribution of 2-chloro-2 '-deoxyadenosine, 2-chloro-2 '-arabino-fluoro-2'-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study

      MEDICAL ONCOLOGY
    87. Paszner, B; Petkau, J; Oger, J
      Neutralising antibodies to interferon-beta in the treatment of multiple sclerosis - Cause for concern?

      CNS DRUGS
    88. Wadhwa, M; Skog, ALH; Bird, C; Ragnhammar, P; Lilljefors, M; Gaines-Das, R; Mellstedt, H; Thorpe, R
      Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF

      CLINICAL CANCER RESEARCH
    89. Kobayashi, H; Tagaya, Y; Han, ES; Kim, IS; Le, N; Paik, CH; Pastan, I; Nelson, DL; Waldmann, TA; Carrasquillo, JA
      Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin 2

      CYTOKINE
    90. Kim, IS; Yoo, TM; Kobayashi, H; Kim, M; Le, N; Wang, Q; Pastan, I; Carrasquillo, JA; Paik, CH
      Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with Tc-99m

      BIOCONJUGATE CHEMISTRY
    91. Bastie, JN; Cazals-Hatem, D; Daniel, MT; D'Agay, MF; Rabian, CL; Glaisner, S; Noel-Walter, MP; Dabout, D; Flandrin, G; Dombret, H; Poisson, D; Degos, L; Castaigne, S
      Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment

      LEUKEMIA & LYMPHOMA
    92. Tetreault, SA; Robbins, BA; Saven, A
      Treatment of hairy cell leukemia-variant with cladribine

      LEUKEMIA & LYMPHOMA
    93. Siegel, RS; Hakimian, D; Spies, W; Wollins, ER; Peterson, LC; Meyer, J; Tallman, MS
      Technetium-99M sulfur colloid scanning and correlative magnetic resonance imaging in patients with hairy cell leukemia and hypocellular bone marrow biopsies after 2-chlorodeoxyadenosine

      LEUKEMIA & LYMPHOMA
    94. Niitsu, N; Honma, Y
      Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    95. Robak, T; Gora-Tybor, J; Urbanska-Rys, H; Krykowski, E
      Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    96. Mejia, C; Navarro, S; Colamonici, OR; Pellin, A; Castel, V; Llombart-Bosch, A
      Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma

      ONCOLOGY REPORTS
    97. Mohammad, RM; Limvarapuss, C; Hamdy, N; Dutcher, BS; Beck, FWJ; Wall, NR; Al-Katib, AM
      Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine

      INTERNATIONAL JOURNAL OF ONCOLOGY
    98. Waller, CF; Fetscher, S; Lange, W
      Treatment-related chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    99. Hellmann, A; Lewandowski, K; Zaucha, JM; Bieniaszewska, M; Halaburda, K; Robak, T
      Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenstrom's macroglobulinemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    100. Robak, T; Blasinska-Morawiec, M; Blonski, J; Hellmann, A; Halaburda, K; Konopka, L; Kotlarek-Haus, S; Potoczek, S; Hansz, J; Dmoszynska, A; Urasinski, I; Zdziarska, B; Dwilewicz-Trojaczek, J; Holowiecki, J; Skotnicki, AB
      2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland

      EUROPEAN JOURNAL OF HAEMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 04:45:03